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Abstract  
Objectives 
Illness perceptions are considered to play an important role in the onset and maintenance of symptoms 
in Functional Neurological Symptom Disorder (Conversion Disorder). There has, however, been little 
work examining differences between subtypes of this disorder. We therefore aimed to compare illness 
perceptions of patients with non-epileptic seizures (NES) and those with functional weakness (FW) 
with matching neurological disease controls to examine their specificity. 
 
Methods 
The Illness Perception Questionnaire Revised (IPQ-R) was completed by patients with functional 
limb weakness, non-epileptic seizures and patients with neurological disease causing limb weakness 
and epilepsy in two separate case control studies.  
 
Results 
Patients with FW (n=107), NES (=40), Epilepsy (n=34) and neurological disease causing limb 
weakness (NDLW) (n=46) were included in the analysis. Both FW and NES patients reported a low 
level of personal control, understanding of their symptoms and a tendency to reject a psychological 
causation of their symptoms. However NES patients rejected psychological causes less strongly than 
FW patients (p<0.01), including the single ‘stress’ item of the IPQ-R (p<0.01). Patients with NES 
were also more likely to consider their treatment to be more effective (p<0.01). None of these 
differences appeared in a similar comparison between patients with epilepsy and patients with NDLW.  
 
Conclusion 
Although patients with NES tend, as a group, to reject psychological factors as relevant to their 
symptoms, they did so less strongly than patients with functional limb weakness in these cohorts. This 
has implications for both the way in which these symptoms are grouped together but also the way in 
which explanations and treatment is approached. 
 
 
 
 
 
 
 
 
Introduction 
 
 
Illness perceptions are considered to have an important impact on outcome in functional neurological 
symptom disorder (FNSD/Conversion Disorder) [1][2]. Compared to patients with similarly disabling 
neurological diseases, such as multiple sclerosis or epilepsy, patients with functional limb weakness 
and non-epileptic seizures typically have quite similar illness perceptions regarding the impact of their 
symptoms but are less likely to endorse psychological factors as causes [3][4][5].  
 
Symptoms of seizures and weakness have always been grouped together within DSM Conversion 
Disorder because: 1) both present to neurological services, 2) they co-exist in the same patient much 
more often than chance, 3) there are patients who have intermediate forms of the disorders (e.g. 
paroxysmal movement disorders that could also be considered 'seizures' or patients whose NES leave 
them with more persistent functional limb weakness), 4) both presentations have traditionally 
been conceptualized to share a similar etiological (psychogenic, conversion) explanation. 
However, data comparing these two groups is scarce [6–9] and no previous studies have focused on 
illness perceptions. 
 
We therefore aimed to compare the illness perceptions of two well-characterised cohorts of patients 
with NES and FW. Additional disease controls with matching symptoms (patients with weakness 
caused by neurological disease or with epilepsy) allowed us to investigate whether any differences 
between groups related specifically to conversion disorder rather than more generally to the 
experience of having attacks or limb weakness. Data from these two cohorts have previously been 
analysed to explore differences between patients with functional and neurological limb weakness [4], 
patients with non-epileptic seizures and their doctors [5], and between relatives of patients with 
functional symptoms or symptoms of neurological disease [10]. However, none of the previous 
studies have examined differences between the two different functional symptom groups and the 
specificity of these.  
 
 
Methods 
Recruitment  
Patients were prospectively and consecutively identified from Clinical Neurology departments with 
the following diagnoses: functional weakness of a limb (FW), neurological disease causing limb 
weakness, (NDLW) (Department of Clinical Neurosciences, Edinburgh (1999-2002) [4]), epilepsy 
(EP) or non-epileptic seizures (NES) (diagnosed on the basis of video EEG recordings of typical 
seizures conforming to a ‘documented’ level of diagnostic certainty, Department Clinical Neurology, 
Sheffield, 2009-11)[5] [11]. Inclusion criteria were: symptom onset within last two years (FW and 
NDLW only since the recruitment protocol for NES did not specify a duration); not “partly 
functional/partly organic diagnosis” / not mixed epileptic and non-epileptic seizures (ES and NES 
only); age over 16, able to read English. Patients completed the Illness Perception Questionnaire-
Revised (IPQ-R)[12] and the Hospital and Anxiety Depression Scale (HADS) [13] after seeing a 
consultant neurologist but prior to being seen by the research fellow for an assessment (FW and 
NDLW) or, in the case of Epilepsy and NES, before the outcome of the video-EEG recording had 
been discussed with them.  
 
Further details of recruitment and other clinical and self-report data can be found elsewhere [4] [5]. 
Ethical approval was provided by the Lothian Research Ethics committee (FW) and Sheffield 
Research Ethics Committee (NES).  
 
Measures and Analysis 
The IPQ-R is a 38-item self-report questionnaire in order to assess patients’ illness perceptions [12]. 
Eight Subscales are rated on a five-point Likert scale ranging from strongly agree to strongly disagree 
(for a detailed description please see below, Table 2). We excluded the Identity subscale, a list of 
physical symptoms, as it was not collected in the seizure samples. Additionally, we grouped a list of 
18 possible "causes" into psychological/emotional (items 1,9-12, and 17; “stress”, “my mental 
attitude”, “family problems”, “overwork”, “my emotional state” and “my personality”) (Cronbach's  
= .864) and non-psychological (items 2-8, 13-16, and 18; e.g. “hereditary”, “germ or virus”, “poor 
medical care in the past”, “accident or injury”).  
The Hospital Anxiety and Depression Scale (HADS) [13] is a widely used and validated measure of 
anxiety and depression in patients with physical symptoms.  
We used SPSS Statistics 21 to compare the functional groups (NES vs FW) and the neurological 
groups (EP vs NDLW) on age, gender, HADS score, and IPQ-R data. We used t-tests where data was 
normally distributed (Kolmogorov Smirnov test) or non-parametric Mann-Whitney U tests where it 
was not. Because of multiple testing, we conservatively interpreted two-sided p values of 0.01 as 
significant. We calculated Cohen’s d effect sizes for significant differences. 
 
 
 Results 
We recruited 107 patients with FW, 46 with NDLW (commonest diagnoses multiple sclerosis (n=27), 
Guillain-Barré syndrome (n=4) and others[4]), 40 with NES and 34 with epilepsy. There were no age 
or gender differences between FW and NES groups (Table 1). Symptom duration in the NES and 
Epilepsy groups was significantly longer compared to the FW and NDLW groups in keeping with 
different recruitment protocols at the two sites. There were no significant differences in anxiety or 
depression scores between patients with FW and NES or between NDLW and epilepsy. 
The IPQ-R results for all four groups are shown in Table 2. Although both NES and FW groups 
tended to reject psychological explanations, NES patients rejected them less strongly than FW 
patients (p<.01, effect size d=0.49, medium effect). This was also true for the single item asking 
whether 'stress' was a possible cause of their illness (p<.01, effect size d=0.56, medium effect). This 
item, together with the other ‘psychological causation’ items are shown in Figure 1 for the FW and 
NES cohorts. 
Although both groups agreed that the conditions had major consequences on their lives, FW patients 
reported a relatively lower effect of the condition on themselves and their families, compared to 
patients with NES (p<.01, effect size d=0.44, small effect).  
NES patients also considered the effectiveness of treatment to be higher than FW patients (p<.01, 
d=0.52, medium effect). 
There were no differences between patients with FW and NES in terms of their perception of the 
cyclical nature or the long duration of their disorders (Timeline), personal control over their condition 
(Personal control) understanding of their condition (Illness Coherence) or the perceived emotional 
impact (Emotional representation).  
Patients with Epilepsy estimated the degree of personal control as significantly lower than patients 
with NDLW (p<.001, effect size d=0.84, large effect). No other differences were found between 
Epilepsy and NDLW. 
Table 1. Demographic and HADS scores in all four groups. 
Overall Condition Functional Neurological Disorders Neurological Disorders 
 Non-
epileptic 
seizures 
(NES) 
(n=40) 
Functional 
weakness 
(FW) 
(n=107) 
Two sided 
p-value 
Epilepsy 
(n=34) 
Neurological 
Weakness 
(NDLW) 
(n=46) 
Two sided 
p-value 
Age 
(yrs, mean, range)
a 
37.0 (18-
66) 
 
39.1 (17-
67) 
 
.41 33.2 (17-64) 39.3 (18-63) .02 
% female
b 
62.5% 79.4% .053  79.4% 82.6% .717 
Median duration of primary 
symptom (months, range)
c 
24 (0-504) 9 (7-27)
 e
 < .001 
 
108 (12-
456) 
11 (1-30)
 e
 < .001 
Mean (s.d.) HADS anxiety score
a d 
10.2 (5.6) 8.6 (5.3)
 
.141 7.9 (4.1) 7.2 (4.7) .500 
Mean (s.d.) HADS depression 
score
a d 
7.8 (5) 7.6 (5.1) .843 5.5 (3.5) 5.8 (4.4) .765 
 
a 
t-test 
b Pearson’s chi-squared test  
c 
Mann-Whitney U test 
d
 data missing for FW n=11, NES n=6, NDLW n=6  
e
 FW (n=2, 25+27 months) and NDLW (n=1, 30 months) had weakness duration over 24 months  
 
 
Table 2. Comparison of adapted IPQ-R scores for all patients with Non-Epileptic Seizures (NES) compared with Functional Weakness (FW), and Epilepsy (EP) compared 
with neurological disease causing limb weakness (NDLW). All scores are normalised to a 1-100 scale. t-test unless otherwise specified. 
IPQ-R subscales Interpretation of higher score IPQ-R score, mean (s.d.) and statistical 
comparison between NES and FW 
IPQ-R score, mean (s.d.) and statistical 
comparison between EP and  NDLW 
Functional Neurological Disorders Neurological Disorders 
NES (n=40) 
 
FW (n=102) Two sided  
p-value 
EP (n=34)
  
NDLW 
(n=43) 
Two sided  
p-value 
Psychological causal 
attributions 
Greater endorsement of six psychological 
causes 
36 (24) 25 (21) .009 39 (19)
b 
35 (20) .403 
Stress (single item) Agrees with stress as a cause of illness 54 (36) 34 (33) .004
a 
67 (30) 59 (29) .241
a 
Consequences Condition has great effect on patient and 
family 
71 (19) 
 
62 (21) 
 
.019
a 
68 (19) 
 
68 (17) 
 
.947 
Treatment control Treatment is effective for condition 61 (15)
b 
 
53 (15) 
 
.004
a 
54 (18) 53 (18) 
 
.819 
Timeline (cyclical) Condition is cyclical 60 (20) 
 
55 (25) .257 63 (17) 
 
54 (22) 
 
.048 
Timeline 
(acute/chronic) 
Condition will have long duration 58 (16) 
 
51 (21) 
 
.041
a 
63 (21) 
 
69 (25) 
 
.250 
Personal control Patient has high level of control over 
condition 
42 (19) 
 
46 (17) 
 
,167 35 (19) 
 
52 (20) 
 
.000 
Illness Coherence Greater understanding of the condition 32 (26)
b 
 
24 (19) 
 
.160
a 
44 (25) 50 (24) 
 
.290 
Emotional 
representations 
Greater emotional impact on patient 62 (27)
c 
56 (22) .261 60 (24) 62 (19) .746 
a
Mann-Whitney U test  
b
data missing for n=1 
c
data missing for n=2 
 
  
Figure 1. Differences in illness perceptions about psychological causes among patients with 
Functional Weakness (FW) and Non-Epileptic Seizures (NES) 
FW n=102, NES n=40  
NES FW
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 Discussion 
Several previous studies have shown that patients with both NES [3][5] and FW [4] tend to reject 
psychological factors as potentially causal factors [14][15]. Reasons for this may include the stigma of 
associated psychological factors when there is no validating disease label and a possible tendency of 
some patients to deny or not to be able to perceive psychological factors of potential relevance 
[16,17]. However, the data here suggests that of these two patient groups, those with FW are even 
more reluctant to endorse psychological factors than those with NES.  
Previous studies comparing these two subgroups of patients have examined demographics, psychiatric 
comorbidity, life events and a history of abuse but not illness perceptions [6–9]. Three studies have 
shown that NES patients are on average younger at onset [6–8] and one highlighted a higher female 
percentage in NES[8] (whereas we found no significant difference).  Two found higher rates of 
previous abuse and stressful life events in NES vs FW patients [6,7], but none have shown convincing 
differences in the frequency of psychiatric comorbidity. We have not found prior studies comparing 
illness perceptions of patients with a motor disorder such as stroke and epilepsy. 
Possible explanations for the observed differences between NES and FW patients include: (1) the 
experience of cognitive symptoms such as fear, derealisation or depersonalisation during NES [18,19] 
or the experience of triggering which may be more likely to be recognised as ‘psychological’ (2) It is 
also possible that NES is a problem in which psychological factors are especially relevant for 
symptom triggering and maintenance as suggested by studies of prior life events and abuse [6,7] and 
studies of threat perception[20]. (3) FW is continuous whereas NES is episodic, making psychological 
factors more plausible (i.e. patients with FW may have weakness all the time but are unlikely to feel 
stressed or upset all the time). (5) Differences may be due to a selection bias since patients were seen 
in different locations and times and had different durations of symptoms, any or all of which may 
have been the principal shaping factor in their perceptions (rather than the nature of their symptoms). 
Somewhat against this is the lack of any similar differences in the disease control groups, which 
shared these potential confounding issues.   
The last explanation is also one of several limitations of this study. In addition, the NES patients 
represent only the subgroup of NES patients who had typical seizures during a video-EEG recording. 
A previous study has suggested that there may be systematic differences between those patients with 
NES who experience a NES during such a brief video-EEG test and those who do not [21]. 
Differential severity of the symptoms could also confound differences in illness perceptions 
irrespective of symptom type. We also note that the patients with seizures contributing to this study 
had had symptoms for longer than those with weakness.  
Despite these limitations, the study offers for the first time a comparison of illness perceptions in 
subgroups of patients with functional neurological symptoms with substantial sample sizes, with 
additional disease controls to examine the specificity of the differences identified. In this study both 
NES and FW groups tended to reject psychological factors as relevant to their symptoms, NES 
patients did so less strongly than patients with FW. If this data does reflect a genuine difference 
between groups it may map on to the common experience of clinicians treating these disorders, that it 
appears easier (although not much easier) to introduce ideas regarding psychological factors and use 
these in treatment in patients with NES compared to FW. Higher dropout rates in a trial of 
psychotherapy for motor disorders [22] compared to a trial for NES [23] lend support to this 
observation.  The data also contribute to the debate regarding whether all functional neurological 
symptom disorders should be lumped together or considered separately [24]. Future studies examining 
a range of other potential predisposing, precipitating and perpetuating factors would help inform this 
debate. 
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